Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
POLYISOPRENE MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Chemical & Materials | Published by: IMARC GROUP | Market: |
| 95 pages | Published: 02-11-2019 |
- Chemical & Materials
- IMARC GROUP
- 95 pages
- Published: 02-11-2019
Polyisoprene is a polymer of isoprene found in the latex of the Hevea Brasiliensis trees and is known as natural rubber. Industrially, it is mainly synthesized from isoprene monomer. It is used in manufacturing tires, latex products, footwear, non-automotive engineering products, belting and hoses, etc. IMARC Group’s latest report “Polyisoprene Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” provides an in-depth analysis of the global polyisoprene market. According to the report, the global demand of polyisoprene has grown at a CAGR of nearly 3% during 2011-2018, driven by its capability to manufacture tires.
The report has analysed the global market for polyisoprene on the basis of end-uses. Polyisoprene has a number of functional qualities which find uses in various industries. Traditionally, natural polyisoprene has been used in tire manufacturing. These days, however, synthetic rubber is substituting natural rubber. Tire and related products segment represents the largest and fastest growing consumer of polyisoprene. Other applications of polyisoprene cover latex products, footwear, non-automotive engineering, belting and hoses.
The report has further analysed market share of key regions. Currently, Russia represents the largest market for synthetic polyisoprene accounting for more than a third of the total global consumption. In case of natural polyisoprene, China represents the largest market. Assessing the global imports and exports of synthetic polyisoprene, the report has found that Poland is the largest global importer of synthetic polyisoprene while Malaysia is the largest importer of natural rubber. Apart from being the largest consumer, Russia also represents the largest exporter of synthetic polyisoprene while Thailand is the largest exporter of natural rubber.
The report has also analysed the competitive landscape of the global polyisoprene market. As the polyisoprene manufacturing process is complex and capital intensive, it is dominated by a handful of companies. Nizhnekamskneftekhim is currently the world’s largest synthetic polyisoprene manufacturer accounting for nearly a third of the total global polyisoprene production. Sri Trang group based in Thailand is the leader in natural rubber production and processing.
This report provides a deep insight into the global polyisoprene industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also gives an in-sight into the manufacturing process of polyisoprene, covering key success and risk factors for manufacturers, detailed process flow, the chemical reactions involved, raw materials and their requirements, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who are planning to foray into the polyisoprene market in any manner.
The essential aspects of the global polyisoprene market evaluated in the report include:
- Market trends
- Major regions
- Key application areas
- Key manufacturers
- Price trends
- Raw material requirements
- Chemical reactions involved in the manufacturing process
- Major importers and exporters
- Value chain analysis
- Market trends for major feedstocks
- Price trends for major feedstocks
- Key regions for major feedstocks
- Key application areas for major feedstocks
- Key players for major feedstocks
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Physical and Chemical Properties 4.3 Key Industry Trends 5. Global Polyisoprene Market 5.1 Market Overview 5.2 Market Performance 5.2.1 Volume Trends 5.2.2 Value Trends 5.3 Market Breakup by Region 5.4 Market Breakup by Type 5.5 Market Breakup by Application 5.5.1 Tires and Related Products 5.5.1.1 Market Trends 5.5.1.2 Market Forecast 5.5.2 Latex Products 5.5.2.1 Market Trends 5.5.2.2 Market Forecast 5.5.3 Footwear 5.5.3.1 Market Trends 5.5.3.2 Market Forecast 5.5.4 Non-Automotive Engineering 5.5.4.1 Market Trends 5.5.4.2 Market Forecast 5.5.5 Belting and Hose 5.5.5.1 Market Trends 5.5.5.2 Market Forecast 5.5.6 Others 5.5.6.1 Market Trends 5.5.6.2 Market Forecast 5.6 Market Forecast 6. Global Natural Polyisoprene Market 6.1 Market Performance 6.1.1 Volume Trends 6.1.2 Value Trends 6.2 Price Trends 6.3 Market Breakup by Region 6.3.1 China 6.3.2 India 6.3.3 United States 6.3.4 Japan 6.3.5 Thailand 6.3.6 Others 6.4 Market Breakup by Key Players 6.5 Imports and Exports 6.6 Market Forecast 7. Global Synthetic Polyisoprene Market 7.1 Market Performance 7.1.1 Volume Trends 7.1.2 Value Trends 7.2 Price Trends 7.3 Market Breakup by Region 7.3.1 Russia 7.3.2 United States 7.3.3 Japan 7.3.4 China 7.3.5 Western Europe 7.3.6 Others 7.4 Market Breakup by Key Players 7.5 Imports and Exports 7.6 Market Forecast 8. Global Polyisoprene Industry Analysis 8.1 SWOT Analysis 8.1.1 Overview 8.1.2 Strengths 8.1.3 Weaknesses 8.1.4 Opportunities 8.1.5 Threats 8.2 Value Chain Analysis 8.2.1 Raw Material Procurement 8.2.2 Manufacturing 8.2.3 Distribution 8.2.4 Export 8.2.5 End-Use 8.3 Product Pricing and Margin Analysis 8.4 Porter’s Five Forces Analysis 8.4.1 Overview 8.4.2 Bargaining Power of Buyers 8.4.3 Bargaining Power of Suppliers 8.4.4 Degree of Competition 8.4.5 Threat of New Entrants 8.4.6 Threat of Substitutes 9. Competitive Landscape 10. Polyisoprene Manufacturing Process 10.1 Product Overview 10.2 Chemical Reactions Involved 10.3 Detailed Process Flow 10.4 Raw Material Requirements 10.5 Mass Balance and Feedstock Conversion Rates 10.6 Key Success and Risk Factors 11. Polyisoprene: Feedstock Analysis 11.1 Isoprene 11.1.1 Market Performance 11.1.1.1 Volume Trends 11.1.1.2 Value Trends 11.1.2 Price Trends 11.1.3 Market Breakup by Region 11.1.4 Market Breakup by Application 11.1.5 Key Manufacturers |
Global Polyisoprene Market
Global Natural Polyisoprene Market
Global Synthetic Polyisoprene Market
Global Polyisoprene Industry Analysis
GCC LED LIGHTING MARKET: INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Technology & Media | Published by: IMARC GROUP | Market: |
| 187 pages | Published: 02-11-2019 |
- Technology & Media
- IMARC GROUP
- 187 pages
- Published: 02-11-2019
Currently, LEDs are the most energy-efficient and one of the rapidly developing lighting technologies in the world. They offer numerous benefits over the conventional lighting technologies. LED lights have a longer lifespan, consumes up to 90% less electricity than the traditional lighting sources and are highly efficient with minimum radiation or heat emission. As a result, LED lights are rapidly replacing incandescent and fluorescent lights in the commercial, industrial and residential sectors in the GCC region.
According to IMARC Group, the LED lighting market in the GCC region has grown at a CAGR of 19.7% during 2015-2018. Factors like growing urbanization rates, infrastructural development and concerns over emission of greenhouse gases are currently driving the growth of the LED lighting market in the GCC countries. Other factors like the new UAE regulations which restrict the imports and sales of incandescent lamps; upcoming events like the World Expo in 2020 and the FIFA World Cup in 2022, the ongoing green building movement, increasing government support and a ban on inefficient lighting technologies are further expected to create a massive demand for LED lighting in the major GCC markets. Currently, Saudi Arabia and UAE represent the two biggest markets for LED lights in the region.
This report provides a deep insight into the GCC LED lights industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a LED lights manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GCC LED lights industry in any manner.
Markets Analysed:
- Global LED lighting market
- GCC region LED lighting market
- Saudi Arabia LED lighting market
- UAE LED lighting market
- Qatar LED lighting market
- Bahrain LED lighting market
- Kuwait LED lighting market
- Oman LED lighting market
Products Manufactured:
- Panel Lights
- Flood Lights
- Down Lights
- Street Lights
- Tube Lights
- Bulbs
Technical and Financial Analysis:
- Manufacturing Process
- Raw Material Requirements
- Land Requirements
- Construction Requirements
- Manpower Requirements
- Utility Requirements
- Packaging Requirements
- Capital Investments
- Operating Expenses
- Incomes
- Profit Margins
- Return on Investment
Key Questions Answered in This Report:
- How has the GCC LED lighting market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global GCC LED lighting industry?
- Which are the key end-use industries in the GCC LED lighting industry?
- What are the various stages in the value chain of the GCC LED lighting industry?
- What are the key driving factors and challenges in the GCC LED lighting industry?
- What is the structure of the GCC LED lighting industry and who are the key players?
- What is the degree of competition in the GCC LED lighting industry?
- What are the profit margins in the GCC LED lighting industry?
- What are the key requirements for setting up LED lights manufacturing plant?
- How LED panel lights are manufactured?
- How LED flood lights are manufactured?
- How LED down lights are manufactured?
- How LED street lights are manufactured?
- How LED tube lights are manufactured?
- How LED bulbs are manufactured?
- What are the various unit operations involved in an LED lights manufacturing plant?
- What is the total size of land required for setting up an LED lights manufacturing plant?
- What are the machinery requirements for setting up an LED lights manufacturing plant?
- What are the raw material requirements for setting up an LED lights manufacturing plant?
- What are the packaging requirements for LED lights?
- What are the transportation requirements for LED lights?
- What are the utility requirements for setting up an LED lights manufacturing plant?
- What are the manpower requirements for setting up an LED lights manufacturing plant?
- What are the infrastructure costs for setting up an LED lights manufacturing plant?
- What are the capital costs for setting up an LED lights manufacturing plant?
- What are the operating costs for setting up an LED lights manufacturing plant?
- What will be the income and expenditures for an LED lights manufacturing plant?
- What is the time required to break-even?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global LED Lighting Industry 5.1 Market Overview 5.2 Market Performance 5.2.1 Volume Trends 5.2.2 Value Trends 5.3 Market Breakup by Region 5.4 Market by LED Products: LED Lamps, Modules and Fixtures 5.4.1 Market Trends 5.4.2 Market Forecast 5.5 Market Breakup by Application 5.6 Market Forecast 6. GCC Region LED Lighting Industry 6.1 Market Overview 6.2 Market Performance 6.3 Comparative Analysis of CFL and LED 6.4 Market Breakup by Product Type 6.5 Market Breakup by Application 6.6 Market Breakup by Country 6.7 Market Breakup by Import and Domestic Manufacturing 6.8 Market Breakup by Public and Private Sectors 6.9 Market Breakup by Indoor and Outdoor Segment 6.10 Market Forecast 6.11 SWOT Analysis 6.11.1 Overview 6.11.2 Strengths 6.11.3 Weaknesses 6.11.4 Opportunities 6.11.5 Threats 6.12 Value Chain Analysis 6.12.1 Primary Raw Material Suppliers 6.12.2 LED Chip Manufacturers 6.12.3 LED Package and Module Manufacturers 6.12.4 Lighting/Electronic Products Manufacturers 6.12.5 Product Distributors 6.12.6 End Users 6.13 Porter’s Five Forces Analysis 6.13.1 Overview 6.13.2 Bargaining Power of Buyers 6.13.3 Bargaining Power of Suppliers 6.13.4 Degree of Competition 6.13.5 Threat of New Entrants 6.13.6 Threat of Substitutes 6.14 Key Success Factors and Risk Factors for LED Manufacturers 6.15 Price Analysis 6.15.1 Key Price Indicators 6.15.2 Price Structure 7. GCC LED Lighting Industry: Key Demand Drivers 7.1 Government’s Push for Sustainable Development in the Region 7.2 Upcoming Events in the GCC Region Demanding Efficient Lighting Solutions 7.3 Government’s Ban on Inefficient Incandescent Bulbs 7.4 Increasing Awareness of LEDs 8. Saudi Arabia LED Lighting Industry 8.1 Market Overview 8.2 Market Performance 8.3 Market Breakup by Application 8.4 Market Breakup by Product Type 8.5 Market Forecast 9. UAE LED Lighting Industry 9.1 Market Overview 9.2 Market Performance 9.3 Market Breakup by Application 9.4 Market Breakup by Product Type 9.5 Market Forecast 10. Other Markets in the GCC Region 10.1 Qatar LED Lighting Market 10.2 Oman LED Lighting Market 10.3 Kuwait LED Lighting Market 10.4 Bahrain LED Lighting Market 11. Competitive Landscape 11.1 Market Structure 11.2 Key Players 12. LED Lights Manufacturing Process 12.1 Panel Light 12.1.1 Product Overview 12.1.2 Manufacturing Process and Process Flow 12.1.3 Raw Material Requirements 12.1.4 Major Machinery Pictures 12.1.5 Suppliers of Raw Materials and Delivery Time 12.2 Down Light 12.2.1 Product Overview 12.2.2 Manufacturing Process and Process Flow 12.2.3 Raw Material Requirements 12.2.4 Major Machinery Pictures 12.2.5 Suppliers of Raw Materials and Delivery Time 12.3 Flood Light 12.3.1 Product Overview 12.3.2 Manufacturing Process and Process Flow 12.3.3 Raw Material Requirements 12.3.4 Major Machinery Pictures 12.3.5 Suppliers of Raw Materials and Delivery Time 12.4 Street Light 12.4.1 Product Overview 12.4.2 Manufacturing Process and Process Flow 12.4.3 Raw Material Requirements 12.4.4 Major Machinery Pictures 12.4.5 Suppliers of Raw Materials and Delivery Time 12.5 Tube Light 12.5.1 Product Overview 12.5.2 Manufacturing Process and Process Flow 12.5.3 Raw Material Requirements 12.5.4 Major Machinery Pictures 12.5.5 Suppliers of Raw Materials and Delivery Time 12.6 Bulb 12.6.1 Product Overview 12.6.2 Manufacturing Process and Process Flow 12.6.3 Raw Material Requirements 12.6.4 Major Machinery Pictures 12.6.5 Suppliers of Raw Materials and Delivery Time 13. Project Details, Requirements and Costs Involved 13.1 Land Requirements and Expenditures 13.2 Construction Requirements and Expenditures 13.3 Plant Machinery 13.4 Raw Material Requirements and Expenditures 13.5 Packaging Requirements and Expenditures 13.6 Transportation Requirements and Expenditures 13.7 Utility Requirements and Expenditures 13.8 Manpower Requirements and Expenditures 13.9 Other Capital Investments 14. Loans and Financial Assistance 15. Project Economics 15.1 Capital Cost of the Project 15.2 Techno-Economic Parameters 15.3 Product Pricing and Margins Across Various Levels of the Supply Chain 15.4 Taxation and Depreciation 15.5 Income Projections 15.6 Expenditure Projections 15.7 Financial Analysis 15.8 Profit Analysis 16. Key Player Profiles |
- Global LED lighting market
- GCC region LED lighting market
- Saudi Arabia LED lighting market
- UAE LED lighting market
- Qatar LED lighting market
- Bahrain LED lighting market
- Kuwait LED lighting market
- Oman LED lighting market
Duchenne Muscular Dystrophy Treatment Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the Duchenne muscular dystrophy (DMD) treatment market include the rising disease burden of Duchenne muscular dystrophy, increasing investments in biopharmaceutical R&D to release novel disease therapies, and increasing awareness campaigns for DMD.
Currently, there is an increase in the number of clinical trials for testing the future treatment for Duchenne muscular dystrophy. The only accepted pharmacological therapy for the treatment of DMD is corticosteroid-based anti-inflammatory treatment.
The rising prevalence of chronic diseases, such as cardiovascular and neurovascular diseases, and arthritis, and increasing healthcare insurance coverage are the major factors likely to accelerate the growth of the market. The pharmaceutical drug discovery and development have also grown rapidly in the past few years. As there have been great breakthroughs in technology in the last few years that may facilitate research processes and as the explosion of science in understanding the causes of diseases has made target selection more rational than ever, almost all major companies are now concentrating on R&D, which is likely to have a major impact on the market in the coming years.
Furthermore, with increasing awareness among people and with the government’s urgency for the treatment of the disease, there is a big opportunity for the companies to conduct their trails and for new drugs launches, due to which, the market is expected to grow in the coming years.
Scope of the Report
As per the scope of the report, Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. It is a rare muscle disease, which majorly affects males. There are novel drugs and therapies, disease-modifying, and mutation-specific therapies that are some of the emerging major breakthroughs in the DMD treatment market.
Key Market Trends
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Segment is Expected to Grow Fastest During the Forecast Period
Corticosteroids are the only known pharmacological treatment for DMD and help to suppress muscle inflammation. This treatment is being limited by its inadequate therapeutic efficacy, and considerable side effects, and hence, non-steroidal anti-inflammatory drugs (NSAIDs) can be used to reduce the inflammation of muscles. The nonsteroidal anti-inflammatory drugs are expected to witness a CAGR of 49.2% over the forecast period.
However, other therapies and treatments include stem cell therapy, repurposing drugs, anti-fibrotics, myostatin inhibition, gene editing (CRISPR/Cas9), etc. Currently, prednisone/prednisolone and deflazacort have been used for the treatment of Duchenne muscular dystrophy, which is expected to drive the growth of the market, over the forecast period.
North American Region holds the Largest Market Share of the Market Currently and is Believed to Follow the Same Trend Over the Forecast Period
North America dominates the global Duchenne muscular dystrophy market, due to new product innovations, high healthcare expenditure, and government awareness programs. The United States has dominated the regional market and is projected to maintain its lead, owing to the rising disease incidence and anticipated launch of promising pipeline candidates. In addition, the market is expected to grow with the increasing clinical trials around the world, especially in the United States and Europe.
Competitive Landscape
With increasing campaigns and awareness programs, the number of patients is expected to come down, and hence, many companies are conducting campaign programs that help to improve focus on medicines for DMD treatment. There are also very few companies for new drug research for rare diseases because it needs bigger funds. Therefore, the market is not well established in many other therapeutic areas. However, it is expected to experience high growth and expand during the forecast period.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Disease Burden of Duchenne Muscular Dystrophy (DMD)
4.2.2 Increasing Investments in Biopharmaceutical R&D to Release Novel Disease Therapies
4.2.3 Increasing Awareness Campaigns for DMD
4.3 Market Restraints
4.3.1 Lack of Standardization to Measure Clinical Efficacy Across All Stages of DMD
4.3.2 Stringent Regulatory Framework with High Product Cost Burden
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Therapeutic Approach and Treatment Type
5.1.1 Molecular-based Therapies
5.1.1.1 Mutation Suppression
5.1.1.2 Exon Skipping
5.1.2 Steroid Therapy
5.1.2.1 Corticosteroids
5.1.3 Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
5.1.4 Other Therapeutic Approaches and Treatment Types
5.2 By End User
5.2.1 Hospitals/Clinics
5.2.2 Ambulatory Centers
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 BioMarin
6.1.2 Bristol-Myers Squibb Company
6.1.3 Fibrogen Inc.
6.1.4 Eli Lilly and Company
6.1.5 Nobelpharma Co. Ltd
6.1.6 NS Pharma Inc.
6.1.7 Pfizer Inc.
6.1.8 PTC Therapeutics
6.1.9 Santhera Pharmaceuticals
6.1.10 Sarepta Therapeutics
7. Market Opportunities and Future Trends
By Therapeutic Approach and Treatment Type
Molecular-based Therapies
Mutation Suppression
Exon Skipping
Steroid Therapy
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Other Therapeutic Approaches and Treatment Types
By End User
Hospitals/Clinics
Ambulatory Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Mexico General Surgical Devices Market – Growth, Trends, and Forecasts (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 74 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 74 pages
- Published: 07-06-2019
Market Overview
The Mexican general surgical devices market is expected to record a CAGR of around 4.8% over the forecast period, 2019-2024. Certain factors that are accelerating the growth of the market include rising demand for minimally invasive devices, technological advancements in general surgical devices, and rising unmet healthcare needs in the country, along with the rising expenditure on health.
This rise in healthcare expenditure is anticipated to accelerate medical infrastructural development, which is likely to fuel the growth of the surgical devices market in Mexico. Major manufacturers of surgical devices are focusing on gaining a foothold in emerging economies, such as Brazil and Mexico, in order to expand their business operations and explore new markets, thus creating an advanced healthcare infrastructure. Thus, increasing healthcare expenditure, strong local manufacturing base, and rapidly developing healthcare infrastructure, have led to increased and advanced surgical procedures performed in this country. Hence, these factors are likely to offer immense growth opportunities in the Mexican surgical procedures market.
Scope of the Report
The general surgical devices are specially designed tools or instruments that serve a specific purpose during a surgery, which include scissors, forceps, surgical needles, etc.
Key Market Trends
Handheld Devices Segment by Product is Expected to Record the Highest CAGR over the Forecast Period
The handheld devices segment of the Mexican general surgical devices market is expected to register the highest CAGR over the forecast period.
The demand for surgical equipment is increasing in response to the rising need for minimally invasive surgeries in the country. Handheld surgical devices are becoming increasingly advanced. The large-scale use of advanced surgical instruments in recent years is driving the handheld devices segment in Mexico. The development of advanced tools, like robotic hand-held surgical devices for laparoscopic interventions, enhances a surgeon’s ability. Many innovations have been made owing to the need for high reliability, accuracy, and patient safety. Therefore, there is an increasing demand for handheld devices, which in turn, is helping the segment to grow faster.
Competitive Landscape
Some of the major companies in the Mexican general surgical devices market are B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Medtronic PLC, and Stryker Corporation. Along with these big players, the market is also witnessing some of the smaller players that hold a substantial market share.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Devices
4.2.2 Technological Advancements in General Surgical Devices
4.2.3 Rising Unmet Healthcare Needs
4.2.4 Rising Health Expenditure
4.3 Market Restraints
4.3.1 High Capital Expenses Needed to Produce Surgical Equipment
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Handheld Devices
5.1.2 Laproscopic Devices
5.1.3 Electro Surgical Devices
5.1.4 Wound Closure Devices
5.1.5 Trocars and Access Devices
5.1.6 Other Products
5.2 By Application
5.2.1 Gynecology and Urology
5.2.2 Cardiology
5.2.3 Orthopaedic
5.2.4 Neurology
5.2.5 Other Applications
6. Competitive Landscape
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Boston Scientific Corporation
6.1.3 Conmed Corporation
6.1.4 Integer Holdings Corporation
6.1.5 Johnson & Johnson
6.1.6 Medtronic PLC
6.1.7 Stryker Corporation
7. Market Opportunities and Future Trends
By Product
Handheld Devices
Laproscopic Devices
Electro Surgical Devices
Wound Closure Devices
Trocars and Access Devices
Other Products
By Application
Gynecology and Urology
Cardiology
Orthopaedic
Neurology
Other Applications
Drug Discovery Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the drug discovery market include the rising prevalence of a wide range of diseases (such as cardiovascular and CNS-related disorders), rising healthcare expenditure, and upcoming patent expiration of blockbuster drugs.
The diverse range of diseases, primarily cardiovascular disease, infectious diseases, diabetes, and kidney-related complications, has a high prevalence, globally. Thus, the increasing prevalence of a diverse range of diseases among all age groups and its burden, globally, drives the demand for drug discovery and its market.
There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics and combinatorial chemistry for better drug candidate identification. Drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time consuming. Due to automation, multi-detector readers, imaging hardware and software, high-throughput screening is one of the most widely used drug discovery technologies.
In recent years, there has been a rising demand for specialty medicines that is expected to ultimately influence the small molecule drug discovery market in a positive manner, as most of the specialty medicines are small molecules.
The gradual rise in the healthcare expenditure regionally helps the new pharmaceutical technology advancement. Although with high expenditure, there is a need for redirecting the resources, the transition toward better usability of healthcare expenditure for drug development is under progress.
Scope of the Report
As per the scope of the report, drug discovery is a process, which aims at identifying a compound therapeutically useful in treating and curing diseases. Typically, a drug discovery effort addresses a biological target that has been shown to play a role in the development of the disease or starts from a molecule with interesting biological activities. In the recent past, drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time consuming.
Key Market Trends
Biologics Drug is the Segment that is Expected to Grow Fastest under Drug Type
A biologic drug is a product that is produced from living organisms or contains components of living organisms. Biologic drugs include a wide variety of products derived from human, animal, or microorganisms. Biologic drugs are used for the treatment of numerous diseases and conditions and are the most advanced therapies available. Biologic treatments are for autoimmune diseases, which include the treatments for rheumatoid arthritis, psoriasis, ulcerative colitis, Crohn’s disease, and a range of related disorders, and have continued to see increasing usage across geographies. The biologic drugs are expected to be fueled by innovations in oncology, autoimmune, and diabetes treatments, with particular important opportunities for biologics in the oncology and autoimmune sectors.
The increasing applications of small molecule drugs for the treatment of chronic diseases are leading to the increased demand for these drugs in the market. Moreover, due to the aforementioned factors, small molecule drugs dominate the biologics in the current healthcare market.
Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend Over the Forecast Period
The Asia Pacific is the fastest-growing region, due to the presence of skilled labor at an affordable cost, the rise in disposable income, and favorable government policies that are contributing to the market growth. There has also been phenomenal growth in the outsourcing companies in the Chinese region, over the last decade, which has complemented the restructuring of the R&D that has taken place. Thus, owing to the large deals of pharmaceutical companies and more number of research being done, the market for drug discovery is expected to grow.
Competitive Landscape
The market studied has various pharmaceutical companies that are investing billions of dollars in artificial intelligence (AI), in order to make the drug discovery process significantly faster and cost efficient. The pharmaceutical and biotech companies are increasing their collaborations with contract development and manufacturing organizations; thus, playing a crucial role in the development and innovation of new drugs.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of a Diverse Range of Diseases
4.2.2 Technological Advancements and Innovations
4.2.3 Increasing Healthcare Expenditure
4.2.4 Patent Expiration of Blockbuster Drugs
4.3 Market Restraints
4.3.1 Huge Capital Investment with Low-profit Margins
4.3.2 Stringent Government Regulations
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Drug Type
5.1.1 Small Molecule Drug
5.1.2 Biologic Drug
5.2 By Technology
5.2.1 High Throughput Screening
5.2.2 Biochips
5.2.3 Bioinformatics
5.2.4 Pharmacogenomics and Pharmacogenetics
5.2.5 Combinatorial Chemistry
5.2.6 Nanotechnology
5.2.7 Spectroscopy
5.2.8 Metabolomics
5.2.9 Other Technologies
5.3 By Service
5.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Services
5.3.2 Pharmaceutical Services
5.3.3 Chemical Services
5.3.4 Biological Services
5.4 By End User
5.4.1 Research Institutes
5.4.2 Pharmaceutical Companies
5.4.3 Contract Research Organizations(CROs)
5.4.4 Other End Users
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 United Kingdom
5.5.2.2 Germany
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Pfizer Inc.
6.1.2 GlaxoSmithKline PLC
6.1.3 Merck & Co. Inc.
6.1.4 Agilent Technologies Inc.
6.1.5 Eli Lilly and Company
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 Bayer AG
6.1.8 Abbott
6.1.9 AstraZeneca PLC
6.1.10 Shimadzu Corp.
7. Market Opportunities and Future Trends
By Drug Type
- Small Molecule Drug
Biologic Drug
By Technology
High Throughput Screening
Biochips
Bioinformatics
Pharmacogenomics and Pharmacogenetics
Combinatorial Chemistry
Nanotechnology
Spectroscopy
Metabolomics
Other Technologies
By Service
Drug Metabolism and Pharmacokinetics (DMPK) Services
Pharmaceutical Services
Chemical Services
Biological Services
By End User
Research Institutes
Pharmaceutical Companies
Contract Research Organizations(CROs)
Other End Users - Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
e-Health Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 115 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 115 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of e-health market include the growth in IoT and technological innovations, rising preference toward mobile technology and internet, and rising demand for population health management. Lifestyle-associated disorders, such as hypertension and diabetes, are expected to increase over the forecast period. These diseases raise the blood pressure and blood sugar levels. Thus, the increasing awareness among people about e-health and rising acceptance level among healthcare professionals, coupled with evidence of the efficiency of using this technology, are anticipated to result in substantial growth for this industry.
In recent years, the number of applications for internet in healthcare has increased exponentially. With the help the internet, healthcare professionals can deliver health information to health consumers more conveniently and in less time. Right from recording the patient entry to discharge, everything is being recorded with the help of the internet. IoT is propelling the market growth majorly in personal e-Health. IoT brings ease and convenience for healthcare providers, as well as for end users. Hence the adoption rate of incorporating it in healthcare is ever increasing, especially in developed countries.
Scope of the Report
As per the scope of the report, e-health is a promising field in public health and business, medical informatics, referring to health services, and information delivered or improved through the internet and related technologies. It empowers patients to take an active role in their treatment, allowing them to gain a deeper understanding of their conditions and how to effectively manage them.
Key Market Trends
Electronic Health Records (EHR) Segment is Expected to Grow the Fastest During the Forecast Period
EHR has been found dominating the overall market, which can be attributed to the growing adoption rate of EHR by many developed and developing countries, globally. EHR also improves the healthcare quality and offers convenience for healthcare providers, in terms of quick access to patient records, improved decision support, provides clinical alerts, and real-time quality reporting. These benefits have thus, contributed to the growth of EHR worldwide.
North American Region Holds the Largest Market Share and is Expected to Follow the Same Trend Over the Forecast Period
North America is expected to be the largest market, due to the presence of technologically updated population base and various current initiatives taken in the region. These aforementioned factors are expected to be the drivers for the market growth. The high growth of this region has also been attributed to the availability of high-tech healthcare infrastructure, along with high-speed internet. Thus the rising awareness is expected to contribute substantially toward the development of the overall market.
Competitive Landscape
The rising focus of the players on technological developments and innovation is expected to fuel the growth of the overall market in the coming few years. As per the study, the competitive scenario of the global e-Health market is likely to intensify with an increasing number of players in the near future.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in IoT and Technological Innovations
4.2.2 Rising Preference Toward Mobile Technology and Internet
4.2.3 Rising Demand for Population Health Management
4.3 Market Restraints
4.3.1 Concerns over Data Security
4.3.2 Lack of Reimbursement Policies in the Emerging Markets
4.3.3 Lack of Proper Infrastructure for e-Health in Emerging Markets
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Type of e-Health
5.1.1 Electronic Health Records
5.1.2 Health Information System
5.1.3 e-Prescribing
5.1.4 Clinical Decision Support Systems
5.1.5 Telemedicine
5.1.6 Other Types of e-Health
5.2 By Type of Service
5.2.1 Monitoring Services
5.2.1.1 Vital Sign Monitoring
5.2.1.2 Special Monitoring
5.2.1.3 Adherence Monitoring
5.2.2 Diagnosis Services
5.2.3 Other Types of Services
5.3 By End User
5.3.1 Hospitals
5.3.2 Insurance Companies
5.3.3 Healthcare Consumers
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Allscripts Healthcare Solutions, Inc.
6.1.2 athenahealth Inc.
6.1.3 Boston Scientific Corporation
6.1.4 Cerner Corporation
6.1.5 CompuMed Inc.
6.1.6 GE Healthcare
6.1.7 IBM
6.1.8 McKinsey & Company
6.1.9 Proteus Digital Health
6.1.10 Telecare Corporation
7. Market Opportunities and Future Trends
By Type of e-Health
- Electronic Health Records
Health Information System
e-Prescribing
Clinical Decision Support Systems
Telemedicine
Other Types of e-Health
By Type of Service
Monitoring Services
Vital Sign Monitoring
Special Monitoring
Adherence Monitoring
Diagnosis Services
Other Types of Services
By End User
Hospitals
Insurance Companies
Healthcare Consumers
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America